FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/16/2022
Back to search
Official data from USPTO
PEREGRINE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PEREGRINE
ST13
US500000079303095Class
5, 42, 44
Filing
79303095
Registration
6641521
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
08/16/2022
Trademark type
Word
Nice classes
5, 42, 44
Filing date
10/26/2020
Registration date
02/15/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/15/2022
Last transaction
02/15/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
78
Owner location
NL
Examiner
RUTLAND, BARBARA
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
SkylineDx B.V.
Representatives
James C. Watson TraskBritt, P.C.
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medical molecular diagnostic test reagents; medical molecular diagnostic test reagents of body substancessuch as bone marrow samplesblood sampleson human or animal tissue; molecular diagnostic test reagents for cancer for medical purposes; medical molecular diagnostic test reagentsinter alia on the basis of microarray technology and sequencing technology; reagents for use in medical genetic testing; reagents for use in medical genetic testing for the measurement of the gene expression profile; reagents for use in medical genetic testing for the measurement of gene aberrations and mutations; clinical diagnostic test reagents for determination of genetic sub-type of a patient; medical prognostic test reagents for testing of bodily fluids for use in disease detectionnamely oncology; predictive test reagentsin search of the effectiveness of a medical treatment and/or to select the medical treatment; diagnostic test reagents and preparations for medical or veterinary purposes; chemical preparationsfor medical purposesfor the testing of blood and human or animal tissueincluding cancer cells; medical diagnostic test strips for tissue-based diagnostics; diagnostic testing materials for medical usenamely oncology; preparations for detecting mutation in human genes for medical purposes
Class 42
Research and development of new products for others; biochemical research and development; pharmaceutical research and development; research and development in the field of diagnostic preparations; biological researchclinical research provided via a website and medical research; scientific research for the benefit of the development of molecular diagnostic tests; analysis and evaluation of results from quality control tests of the goods of others to determine conformity with certification standards; molecular diagnostic analysis; investigation and analysis of body substances and molecular diagnostic test scores for the purpose of the development of new biomarkers development and diagnostic testing of treatment methods for scientific research for medical purposes; development and testing services for the certification of quality or standards of molecular diagnostic tests; computer aided diagnostic testing services for others in the field of science and research related thereto; scientific research for medical purposes in the area of cancerous diseases; genetic testing for scientific research purposes; research of pharmaceutical preparations in the field of gene therapy; providing information about medical research in the field of diagnostic testing services in the field of skin cancer
Class 44
Medical analysis services for diagnostic and treatment-decision purposes provided by medical laboratories; medical analysis for diagnostic and treatment-decision purposes provided by medical laboratories using test scores and data for medical or veterinary purposes for others; medical and veterinary information services provided via the internet; medical testing for diagnostic or treatment purposes; medical diagnostic testingmonitoring and reporting services; medical analysis services for cancer diagnosis and prognosis; medical services for the treatment of skin cancer; medical analysis services for the diagnosis of cancer
Publications
History of USPTO decisions and trademark events.
26 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/22/2022
FIMP
FINAL DISPOSITION PROCESSED
07/22/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/15/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
02/15/2022
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
01/02/2022
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
09/23/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/24/2021
PUBO
PUBLISHED FOR OPPOSITION
08/24/2021
GPNX
NOTIFICATION PROCESSED BY IB
08/22/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/04/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/04/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/04/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/16/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/09/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/08/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/08/2021
RFNT
REFUSAL PROCESSED BY IB
04/25/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/08/2021
RFRR
REFUSAL PROCESSED BY MPU
04/08/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/01/2021
CNRT
NON-FINAL ACTION WRITTEN
03/31/2021
DOCK
ASSIGNED TO EXAMINER
03/26/2021
MAFR
APPLICATION FILING RECEIPT MAILED
02/02/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/29/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/28/2021
Continuous trademark protection
Get notified about every new filing that threatens PEREGRINE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.